Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL04
- Pharmacological subgroupL04A
- Chemical subgroupL04AC
- Chemical substanceL04AC02Basiliximab
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Serbia
ALIMS · 8 registrations
- Simulect®20mg/5mL · prašak i rastvarač za rastvor za injekciju/infuziju · PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd) · 2 entries
- Simulect®20mg · prašak za rastvor za injekciju/infuziju · PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd) · 2 entries
Spain
AEMPS · 2 registrations
- SIMULECT 20 mg POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE O PARA PERFUSION20 mg · polvo y disolvente para solución inyectable · Novartis Europharm Limited
- SIMULECT 10 mg POLVO Y DISOLVENTE PARA SOL. INY. O SOL. PARA PERFUSION10 mg · polvo y disolvente para solución inyectable · Novartis Europharm Limited
Netherlands
At a glance
- ATC code
- L04AC02
- Registers
- 10
- Historical lists
- 2
- Registrations
- 23
- With their own page
- 19
- Companies
- 8
All medicines with Basiliximab
Human medicines from every register that match Basiliximab by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
24 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Simulect | United States | 10MG, 20MG | vial | Marketed | Novartis |
| Simulect | European Union | Authorised | Novartis Europharm Limited | ||
| SIMULECT 20 mg POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE O PARA PERFUSION | Spain | 20 mg | polvo y disolvente para solución inyectable | Marketed | Novartis Europharm Limited |
| Simulect 10 mg, poeder en oplosmiddel voor oplossing voor intraveneuze infusie | Netherlands | Poeder voor oplossing voor injectie of infusie, Poeder en oplosmiddel voor oplossing voor injectie | Authorised | Novartis Europharm Limited | |
| SIMULECT 10 mg POLVO Y DISOLVENTE PARA SOL. INY. O SOL. PARA PERFUSION | Spain | 10 mg | polvo y disolvente para solución inyectable | Authorised | Novartis Europharm Limited |
| Simulect 20 mg, poeder en oplosmiddel voor oplossing voor intraveneuze infusie | Netherlands | Poeder en oplosmiddel voor oplossing voor infusie, Poeder voor oplossing voor injectie of infusie | Authorised | Novartis Europharm Limited | |
| Simulect | Canada | 20 MG / VIAL | Powder For Solution | Marketed | Novartis Pharmaceuticals Canada INC |
| Simulect | Brazil | Authorised | Novartis Biociencias S.A | ||
| SIMULECT FOR INJECTION 20 mg/vial | Singapore | 20 mg/vial | injection, powder, for solution | Authorised | Novartis (Singapore) Pte LTD |
| Simulect® | Serbia | 20mg/5mL | prašak i rastvarač za rastvor za injekciju/infuziju | Authorised | PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd) |
| Simulect® | Serbia | 20mg | prašak za rastvor za injekciju/infuziju | Authorised | PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd) |
| Simulect® | Serbia | 20mg/5mL | prašak i rastvarač za rastvor za injekciju/infuziju | Authorised | PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd) |
| Simulect® | Serbia | 20mg | prašak za rastvor za injekciju/infuziju | Authorised | PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd) |
| Simulect® | Serbia | 20mg/5mL | prašak i rastvarač za rastvor za injekciju/infuziju | Authorised | PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd) |
| Simulect® | Serbia | 20mg | prašak za rastvor za injekciju/infuziju | Authorised | PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd) |
| Simulect® | Serbia | 20mg/5mL | prašak i rastvarač za rastvor za injekciju/infuziju | Authorised | PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd) |
| Simulect® | Serbia | 20mg | prašak za rastvor za injekciju/infuziju | Authorised | PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd) |
| Simulect | Croatia | Marketed | |||
| Simulect | New Zealand | Inj 20 mg vial | Funded | ||
| Simulect 20 MG I.V Vial | Saudi Arabia | Authorised | Patheon Italia S.P.A. | ||
| Simulect 20 MG I.V Vial | Saudi Arabia | Authorised | Novartis | ||
| Basiliximab | Brazil | Cancelled | Novartis Biociencias S.A | ||
| SIMULECT 20 mg | Romania | 20mg | pulb. + solv. pt. sol. inj. sau perf. | Status unknown | Novartis Europharm Limited |
| SIMULECT 20mg | Romania | 20mg | liof. + solv. pt. sol. inj. / perf. | Status unknown | Novartis Europharm LTD |